Updates in Immunotherapy for Pancreatic Cancer

被引:0
|
作者
Chick, Robert Connor [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA
关键词
pancreatic cancer; immunotherapy; personalized; tumor microenvironment; immune checkpoint inhibitor; cancer vaccine; T-CELLS; TUMOR MICROENVIRONMENT; CHECKPOINT INHIBITORS; STROMAL INFLAMMATION; NEOADJUVANT THERAPY; OPEN-LABEL; COMBINATION; TRIAL; PEMBROLIZUMAB; FOLFIRINOX;
D O I
10.3390/jcm13216419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited effective therapeutic options. Due to a variety of cancer cell-intrinsic factors, including KRAS mutations, chemokine production, and other mechanisms that elicit a dysregulated host immune response, PDAC is often characterized by poor immune infiltration and an immune-privileged fibrotic stroma. As understanding of the tumor microenvironment (TME) evolves, novel therapies are being developed to target immunosuppressive mechanisms. Immune checkpoint inhibitors have limited efficacy when used alone or with radiation. Combinations of immune therapies, along with chemotherapy or chemoradiation, have demonstrated promise in preclinical and early clinical trials. Despite dismal response rates for immunotherapy for metastatic PDAC, response rates with neoadjuvant immunotherapy are somewhat encouraging, suggesting that incorporation of immunotherapy in the treatment of PDAC should be earlier in the disease course. Precision therapy for PDAC may be informed by advances in transcriptomic sequencing that can identify immunophenotypes, allowing for more appropriate treatment selection for each individual patient. Personalized and antigen-specific therapies are an increasing topic of interest, including adjuvant immunotherapy using personalized mRNA vaccines to prevent recurrence. Further development of personalized immune therapies will need to balance precision with generalizability and cost.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] The dark side of immunotherapy: pancreatic cancer
    Mucciolo, Gianluca
    Roux, Cecilia
    Scagliotti, Alessandro
    Brugiapaglia, Silvia
    Novelli, Francesco
    Cappello, Paola
    CANCER DRUG RESISTANCE, 2020, 3 (03) : 491 - 520
  • [42] Pancreatic Cancer and Immunotherapy: A Clinical Overview
    Timmer, Florentine E. F.
    Geboers, Bart
    Nieuwenhuizen, Sanne
    Dijkstra, Madelon
    Schouten, Evelien A. C.
    Puijk, Robbert S.
    de Vries, Jan J. J.
    van den Tol, M. Petrousjka
    Bruynzeel, Anna M. E.
    Streppel, Mirte M.
    Wilmink, Johanna W.
    van Der Vliet, Hans J.
    Meijerink, Martijn R.
    Scheffer, Hester J.
    de Gruijl, Tanja D.
    CANCERS, 2021, 13 (16)
  • [43] Immunotherapy Shows Promise in Pancreatic Cancer
    Caruso, Catherine
    CANCER DISCOVERY, 2019, 9 (10) : 1330 - 1330
  • [44] Immunotherapy and Pancreatic Cancer: A Lost Challenge?
    Laface, Carmelo
    Memeo, Riccardo
    Maselli, Felicia Maria
    Santoro, Anna Natalizia
    Iaia, Maria Laura
    Ambrogio, Francesca
    Laterza, Marigia
    Cazzato, Gerardo
    Guarini, Chiara
    De Santis, Pierluigi
    Perrone, Martina
    Fedele, Palma
    LIFE-BASEL, 2023, 13 (07):
  • [45] EXPERIMENTAL IMMUNOTHERAPY OF PANCREATIC-CANCER
    KLAPDOR, R
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1987, 2 (03) : 205 - 206
  • [46] Recent advances in immunotherapy for pancreatic cancer
    Chi, Jeffrey
    Patel, Rajvi
    Rehman, Hasan
    Goyal, Shreya
    Saif, Muhammad Wasif
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [47] Modeling Pancreatic Cancer Dynamics with Immunotherapy
    Hu, Xiaochuan
    Ke, Guoyi
    Jang, Sophia R. -J.
    BULLETIN OF MATHEMATICAL BIOLOGY, 2019, 81 (06) : 1885 - 1915
  • [48] Modeling Pancreatic Cancer Dynamics with Immunotherapy
    Xiaochuan Hu
    Guoyi Ke
    Sophia R.-J. Jang
    Bulletin of Mathematical Biology, 2019, 81 : 1885 - 1915
  • [49] Laser immunotherapy for metastatic pancreatic cancer
    Zhou, Feifan
    BIOPHOTONICS AND IMMUNE RESPONSES XII, 2017, 10065
  • [50] Facts and Hopes in Immunotherapy of Pancreatic Cancer
    Bockorny, Bruno
    Grossman, Joseph E.
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2022, 28 (21) : 4606 - 4617